Author

Andrey Baranovsky

FILGOTINIB, A SELECTIVE JAK1 INHIBITOR, INDUCES CLINICAL REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE CROHN?S DISEASE: FINAL ANALYSIS OF THE PHASE 2 FITZROY STUDY

Severine Vermeire, Stefan Schreiber, R. Petryka, Tanja Kuehbacher, Xavier Hebuterne, Xavier Roblin, Maria Klopocka, Eugen-Adrian Goldis, Maria Wisniewska Jarosinska, Andrey Baranovsky, Robert Sike, Kremana Stoyanova, Chantal Tasset, Annegret Van der Aa, Pille Harrison

Item 1 - 1 / 3
1